SRT1720 is primarily researched for its potential therapeutic applications in various metabolic and age-related diseases. It is known to activate sirtuins, particularly SIRT1, which play a role in regulating cellular processes such as metabolism, inflammation, and stress resistance. This compound has been studied for its potential to improve insulin sensitivity and glucose metabolism, making it a candidate for managing type 2 diabetes. Additionally, SRT1720 has shown promise in enhancing mitochondrial function and promoting cellular health, which could be beneficial in combating age-related disorders and neurodegenerative diseases. Research also explores its role in reducing oxidative stress and inflammation, suggesting potential applications in cardiovascular diseases and other inflammatory conditions. However, its clinical use remains under investigation, and further studies are needed to confirm its efficacy and safety in humans.